FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions
In a stark warning to Chinese food exporters, the U.S. Food and Drug Administration (FDA) issued multiple automatic detention alerts in early November 2025, targeting firms from Ningxia to Fujian for serious compliance failures. Under Import Alert 99-32, three companies—including Anhui Dong Bao Food and Zhangzhou Zishan Food Industry—were flagged for refusing FDA inspections, a grave violation that triggers immediate shipment holds without testing.
Others faced detentions for pesticide residues: Ningxia Lihe Food’s dehydrated spinach powder contained bromoprophos, lambda-cyhalothrin, and haloxyfop, while Gui Nan Hong Company’s wampee plums exceeded sulfur dioxide limits.
These actions fall under FDA’s Detention Without Physical Examination (DWPE) authority—meaning every future shipment from these firms will be blocked at U.S. ports until they prove compliance through third-party lab results and FDA reapproval. Refusing inspection is treated as an admission of non-compliance, making reinstatement arduous. For China’s agri-food sector, this signals tightening U.S. scrutiny and zero tolerance for opacity.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
China NMPA Issues Priority Review Pathway for Four Categories of Chemical Active Pharmaceutical Ingredients, Effective August 1, 2026
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
The FDA Officially Blesses AI for Liver Drug Development
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
U.S. Imposes 12.5% Additional Tariff! Nutritional Ingredients Including Creatine, Taurine, and Glucosamine Included in New Section 301 Tariff List
Recommend Reading
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
In November, the coke market in China was mainly strong.
-
At the end of the month, the 180CST fuel oil market in China remains stable
-
Permanganate: Properties, Uses, and Safety
-
Demand Performance Flat, November Polyester Staple Fiber Prices Fluctuate and Weaken in China
-
Improved Supply-Demand Dynamics Drive PTA Prices to Fluctuate and Rise in November